期刊文献+

妊娠中期妇女超甲基化RASSF1A基因表达水平与子痫前期的关系 被引量:1

Relationship between pre-eclampsia and maternal expression of the hypermethylated RASSF1A gene during the second trimester
下载PDF
导出
摘要 目的 探讨妊娠中期妇女血浆中超甲基化RASSF1A基因表达水平变化与子痫前期的关系。方法 选择规律产前检查孕妇506例,分别于孕15-19周及孕20-24周采外周血,同时监测孕妇血压、尿蛋白值,其中诊断为妊娠期高血压疾病的孕妇中包括子痫前期组(48例)、妊娠期高血压组(48例),从同期单胎健康孕妇中随机选取96名为对照组。收集入组孕妇外周血,提取游离DNA,经甲基化敏感的限制性内切酶消化处理,联合荧光定量PCR检测血浆中超甲基化RASSF1A基因的表达水平,分析其与子痫前期的关系。结果 孕15-19周,子痫前期组及妊娠期高血压组的超甲基化RASSF1A基因表达水平均高于对照组(P〈0.05),子痫前期组与妊娠期高血压组组间比较差异无统计学意义(P〉0.05)。孕20-24周,子痫前期组孕妇血浆中超甲基化RASSF1A基因表达水平高于妊娠期高血压组及正常妊娠组(P〈0.05),妊娠期高血压组孕妇血浆中超甲基化RASSF1A基因表达水平亦高于正常妊娠组(P〈0.05)。结论 妊娠中期妇女血浆中超甲基化RASSF1A基因水平升高可能提示子痫前期的发生。 Objective This study sought to investigate the relationship between pre-eclampsia and the expression of the hypermethylated RASSF1A gene in maternal plasma during the second trimester. Methods Peripheral blood samples were collected at 15 - 19 and 20 - 24 weeks of gestation from 506 pregnant women who received regular prenatal examinations. The blood pressures and urine protein levels of these women were monitored, and women who were diagnosed with gestational hypertension were divided into a pre-eclampsia group (48 subjects) and gestational hypertension group (48 subjects). A total of 96 healthy women with singleton pregnancies during the same time period were included in the control group. Free DNA was extracted from peripheral blood samples from the included pregnant women and then digested with a methylation-sensitive restriction endonuclease. Plasma expression levels of the hypermethylated RASSF1A gene were determined using fluorescence quantitative polymerase chain reaction (PCR), and the relationship between these levels and pre-eclampsia was analyzed. Results At 15 - 19 weeks of gestation, both the pre-eclampsia group and the gestational hypertension group exhibited higher hypermethylated RASSF1A expression than that of the control group (P 〈 0. 05 ), whereas no significant differences between the pre-eclampsia group and the gestational hypertension group were observed (P 〉 0. 05 ). At 20 - 24 weeks of gestation, plasma RASSF1A expression was higher in the pre-eclampsia group than in the gestational hypertension group or the control group (P 〈 0. 05 ), and plasma RASSF1A expression was higher in the gestational hypertension group than in the control group (P 〈 0. 05). Conclusion Elevated hypermethylated RASSF1A expression in maternal plasma during the second trimester may indicate the onset of pre-eclampsia.
出处 《新医学》 2015年第7期444-447,共4页 Journal of New Medicine
基金 深圳市龙岗区科技计划(YLWSF20140611094017602)
关键词 子痫前期 超甲基化RASSF1A基因 胎儿游离DNA Pre-eclampsia Hypermethylated RASSFIA Cell-free fetal DNA
  • 相关文献

参考文献12

  • 1Duley L. The global impact of pre-eclampsia and eclap- sia. Semin Perinatol, 2009, 33 (3) : 130-137.
  • 2Wald NJ, Bestwick JP, George LM, Wu T, Morris JK. Screening for preeclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers. J Med Screen, 2012, 19 (2) : 60-67.
  • 3Hahn S, Huppertz B, Holzgreve W. Fetal cells and cell free fetal nucleic acids in maternal blood : new tools to study abnormal placentation. Placenta, 2005, 26 (7) : 515-526.
  • 4Orozco AF, Jorgez C J, Ramos-Perez WD, Popek EJ, Yu X, Kozinetz CA, Bischoff FZ, Lewis DE. Placental release of distinct DNA-associated micro-particles into maternal circulation : reflective of gestation time and pre- eclampsia. Placenta, 2009, 30 (10): 891-897.
  • 5Redman CW, Sargent IL. Placental stress and pre- eclampsia: a revised view. Placenta, 2009, 30 (Sup- plA) : s38-s42.
  • 6Sikora A, Zimmerman BG, Rusterholz C, Birri D, Kol- la V, Lapaire O, Hoesli I, Kiefer V, Jackson L, Hahn S. Detection of increased amounts of cell-free fetal DNA with short PCR amplicons. Clin Chem, 2010, 56 (1) : 136-138.
  • 7Scheffer PG, van der Schoot CE, Page-Christiaens GC, Bossers B, van Erp F, de Haas M. Reliability of fetal sexdetermination using maternal plasma. Obstet Gyne- col, 2010, 115 (1): 117-126.
  • 8郑伏甫,戴宇平,徐理华,邓春华,郑克立.肾癌组织中BHD、RASSF1A、SPINT2基因启动子的甲基化研究[J].新医学,2010,41(6):358-361. 被引量:2
  • 9Bellido ML, Radpour R, Lapaire O, De Bie I, Husli I, Bitzer J, Hmadcha A, Zhong XY, Holzgreve W. MAL- DI-TOF mass array analysis of RASSFIA and SERPINB5 methylation patterns in human placenta and plasma. Biol Reprod, 2010, 82 (4) : 745-750.
  • 10Kim MJ, Kim SY, Park SY, Ahn HK, Chung JH, Ryu HM. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications. Placenta, 2013, 34 (1): 57-61.

二级参考文献20

  • 1崔静,李庚,千新来.P27基因甲基化与结直肠癌发生发展及临床生物学行为的关系[J].新医学,2005,36(3):145-147. 被引量:6
  • 2YAMAUCHI M, KATAOKA H, ITOH H, et al. Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and downregulated in renal cell carcinoma[J]. J Urol, 2004, 171 (2Pt1) : 890-896.
  • 3MORRIS M R, GENTLE D, ABDULRAHMAN M, et al. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2 / SPINT2 in papillary and clear cell renal cell carcinoma [J]. Cancer Res, 2005, 65 (11) :4598-4606.
  • 4MATSUDA Y, ICHIDA T, MATSUZAWA J, et al. p16 (INK4) is inactivated by extensive CpG methyla'tion in human hepatocellular carcinoma [ J ] . Gastroenterology, 1999, 116 (2): 394-400.
  • 5KIRKALI Z, TUZEL E, MUNGAN M U. Recent advances in kidney cancer and metastatic disease[ J]. BJU Int, 2001, 88 (8) : 818-824.
  • 6JONES P A, BAYLIN S B. The fundamental role of epigenetic events in cancer[ J]. Nat Rev Genet, 2002, 3 (6) : 415-428.
  • 7MAEKAWA M, WATANABE Y. Epigenetics : relations to disease and laboratory findings [ J ]. Curr Med Chem, 2007, 14 (25):2642-2453.
  • 8SINGER-SAM J, GRANT M, LEBON J M, et al. Use of a Hpall-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island ofmouse embryos at the time of X-chromosome inactivation [ J ]. Mol Cell Biol, 1990, 10 (9): 49874989.
  • 9HERMAN J G, GRAFF J R, MYOHANEN S, et al. Methylation-specific PCR: a novel PCR assay formethyl- ation status of CpG islands [ J ]. Proc Natl Acad Sci USA, 1996, 93 (18): 9821-9826.
  • 10SCHMIDT L S, WARREN M B, NICKERSON M L, et al. Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11. 2[J]. Am J Hum Genet, 2001, 69 (4): 876-882.

共引文献1

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部